Newly awarded NIH NIDDK R25 grant establishes Washington University as a coordinating center for the Short-Term Research Experience Program to Unlock Potential (STEP-UP) The Institute of Clinical and Translational Sciences (ICTS) Clinical Research Training Center (CRTC) received a R25 grant in May 2022 establishing Washington University School of Medicine in St. Louis as a coordinating […]
The Washington University Institute of Clinical and Translational Sciences announces five partnerships selected to receive funding through the 2022-2023 Partnership Development and Sustainability Support (PDSS) program. This funding program provides up to $10,000 to new and existing community-academic partnerships for a 10-month period. It enables partners to develop the trust, infrastructure, capacity and skills needed […]
Since the inception of the ICTS in 2007, pilot funding opportunities have provided investigators with support for promising and innovative translational research. Frequently, this pilot funding begets research and novel findings that assist investigators in applying for additional grant mechanisms. In 2019, Guoyan Zhao, PhD, assistant professor in the Department of Neuroscience at Washington University […]
ST. LOUIS – Dhiren Patel, MD, associate professor of pediatrics at SLU’s School of Medicine and SLUCare pediatric gastroenterologist, was awarded a $50,000 grant by the Institute of Clinical and Translational Sciences (ICTS), a Washington University-led research consortium, of which Saint Louis University is a member.
ST. LOUIS – Devita Stallings, PhD, RN to BSN program coordinator and associate professor of nursing at Saint Louis University’s Trudy Busch Valentine School of Nursing, was awarded a $50,000 grant by the Institute of Clinical and Translational Sciences (ICTS), a Washington University-led research consortium, of which Saint Louis University is a member.
A large randomized, placebo-controlled clinical trial led by the National Institutes of Health shows that treating adults hospitalized with COVID-19 with infliximab or abatacept – drugs widely used to treat certain autoimmune diseases – did not significantly shorten time to recovery but did substantially improve clinical status and reduce deaths.
As an undergraduate double major in English and Biology, Jennie Kwon, DO, MSCI, might have had a hard time predicting her eventual career path. But, during her first semester in medical school, Kwon admitted she was “bit by the proverbial microbiology bug”. “I was truly fascinated by these organisms,” recalls Kwon. “And I knew immediately that […]
Such prescriptions can cause complications including diarrhea, rashes